NCT05089851View on ClinicalTrials.gov

Investigation of the Efficacy and Tolerability of a Cosmetic Product With Onabotulinumtoxin A in the Treatment of Facial Lines

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 23, 2020

Primary Completion Date

June 3, 2021

Study Completion Date

June 3, 2021

Conditions
WrinklesPhotoagingFine Lines
Interventions
PROCEDURE

Onabotulinumtoxin A

Subjects will receive 20 - 24 units to the crows feet (10 - 12 units per side)

COMBINATION_PRODUCT

Facial Cleanser

Facial Cleanser to be used by participants twice daily

COMBINATION_PRODUCT

Facial Moisturizer

Bland moisturizer to be used by study participants after serum twice daily.

COMBINATION_PRODUCT

Sunscreen

Bland Sunscreen to be used by study participants after serum and moisturizer in the morning. Sunscreen to be reapplied if continuous sun exposure occurs.

Trial Locations (3)

33301

Shino Bay Cosmetic Dermatology and Laser Institute, Fort Lauderdale

43215

Juvly Aesthetics, Columbus

52241

Infinity Skin Care, Coralville

All Listed Sponsors
lead

Revision Skincare

INDUSTRY

NCT05089851 - Investigation of the Efficacy and Tolerability of a Cosmetic Product With Onabotulinumtoxin A in the Treatment of Facial Lines | Biotech Hunter | Biotech Hunter